Office of Diversity and Leadership

David K. Stevenson, M.D.

Publication Details

  • Inhaled nitric oxide in infants >1500 g and <34 weeks gestation with severe respiratory failure.

    Van Meurs KP, Hintz SR, Ehrenkranz RA, Lemons JA, Ball MB, Poole WK, Perritt R, Das A, Higgins RD, Stevenson DK. J Perinatol. 2007; 27 (6): 347-52

    Inhaled nitric oxide (iNO) use in infants >1500 g, but <34 weeks gestation with severe respiratory failure will reduce the incidence of death and/or bronchopulmonary dysplasia (BPD).

    PubMedID: 17443204

Stanford Medicine Resources:

Footer Links: